310. 先天異常症候群 Disease details / Clinical trials / Drug dev / DR info

Antioxidants
   University of Colorado, Denver
      2008   Phase 2   NCT01773278   United States
Cholesterol
   University of Colorado, Denver
      2008   Phase 2   NCT01773278   United States
Cholesterol supplementation
   Oregon Health and Science University
      2011   -   NCT01356420   United States
Cholesterol suspension
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1998   -   NCT00001721   United States
Cholic acid
   University of Nebraska
      2021   Phase 1/Phase 2   NCT03720990   United States
CRH
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1998   -   NCT00001721   United States
Crystalline cholesterol OIL-based suspension
   Boston Children’s Hospital
      1998   Phase 1/Phase 2   NCT00272844   United States
DHC
   Obstetrics and Gynecology Hospital Affiliated to Fudan University
      2020   Phase 0   ChiCTR2000035477   China
EGG substitute, without cholesterol
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2005   Phase 2   NCT00114634   United States
EGG yolk preparation with cholesterol
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2005   Phase 2   NCT00114634   United States
Lactose
   Oregon Health and Science University
      2011   -   NCT01434745   United States
Lithium carbonate capsule
   University of Milan
      2024   Phase 2/Phase 3   NCT06789783   Italy
Lovastatin
   Northwestern University
      2011   Phase 2   NCT01110642   United States
N-acetyl cysteine
   Johns Hopkins University
      2025   Phase 2   NCT04381897   United States
Oraplus
   Forbes Porter, M.D.
      2003   Phase 2   NCT00064792   United States
Simvastatin
   Forbes Porter, M.D.
      2003   Phase 2   NCT00064792   United States
   Oregon Health and Science University
      2011   -   NCT01434745   United States